Walmsley will succeed Witty as GSK's CEO

20 September 2016 - Deborah Wilkes

Archived

GlaxoSmithKline has named Emma Walmsley – currently head of its Consumer Healthcare division – as chief executive officer designate. She will take over from Sir Andrew Witty when he retires on 31 March 2017.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: